Homarylamine

Source: Wikipedia, the free encyclopedia.
(Redirected from
Methylenedioxymethylphenethylamine
)
Homarylamine
Clinical data
Other names1,3-benzodioxolyl-N-methyl-5-ethanamine;
3,4-methylenedioxy-N-methyl-2-phenylethylamine;
Norlobivine
Routes of
administration		Various
Legal status
Legal status
  • US-SCHEDULE I DRUG as Positional isomer of MDA
Identifiers
  • 2-(1,3-Benzodioxol-5-yl)-N-methylethanamine
JSmol)
  • CNCCC1=CC2=C(C=C1)OCO2
  • InChI=1S/C10H13NO2/c1-11-5-4-8-2-3-9-10(6-8)13-7-12-9/h2-3,6,11H,4-5,7H2,1H3
  • Key:OPJOMVMFYOUDPK-UHFFFAOYSA-N
  (verify)

Homarylamine (

antitussive (anti-cough) drug[2] which was patented in 1956 by Merck & Co.,[3]
but has never been used medically as such.

Chemically it is a

methylenedioxyphenethylamine
(MDPEA). It is a schedule I drug in the USA as a positional isomer of MDA.

Methylenedioxyphenethylamine
(MDPEA) for comparison

Reactions

Reaction of homoarylamine with formaldehyde gives hydrastinine.

See also

  • Hydrastine, an alkaloid derivative of homarylamine

References

  1. ^ "International Non-Proprietary Names for Pharmaceutical Preparations" (PDF). Chronicle of the World Health Organization. 12 (3). 1958.
  2. doi:10.1002/jps.2600500309
    .
  3. ^ U.S. patent 2,820,739



drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Homarylamine&oldid=1082812409"